Back to Search
TRACY BRIDGES, MD
MD
Allergy & Immunology Physician
NPI: 1386749117IndividualAccepts Medicare
Specialties, Licenses & Credentials
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
038186(GA)
CMS Specialties
PrimaryALLERGY/IMMUNOLOGY
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 1989
Research & Publications (20)
Enabled and Capping protein play important roles in shaping cell behavior during Drosophila oogenesis.
PMID 19576200·Dev Biol·2009
7-preclinical
Field application of activated carbon amendment for in-situ stabilization of polychlorinated biphenyls in marine sediment.
PMID 19544893·Environ Sci Technol·2009
7-preclinical
Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches.
PMID 19619890·Sci Total Environ·2009
6-review
A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
PMID 19407080·Mol Pharmacol·2009
7-preclinical
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
PMID 19438238·J Med Chem·2009
7-preclinical
Degeneracy of the action-frequency map: a mechanism for homoclinic bifurcation of invariant tori.
PMID 19658617·Phys Rev E Stat Nonlin Soft Matter Phys·2009
8-other
A comparison of acute and chronic toxicity methods for marine sediments.
PMID 19481793·Mar Environ Res·2009
7-preclinical
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
PMID 19047481·Mol Pharmacol·2009
4-observational
G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
PMID 18652471·ACS Chem Biol·2008
6-review
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.
PMID 18772318·J Pharmacol Exp Ther·2008
7-preclinical
Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.
PMID 18805692·Bioorg Med Chem Lett·2008
8-other
Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.
PMID 18829311·Bioorg Med Chem Lett·2008
8-other
Design of potent GlyT1 inhibitors: in vitro and in vivo profiles.
PMID 19051137·Curr Opin Mol Ther·2008
6-review
Evidence of an internecine conflict within the practice of environmental risk assessment?
PMID 18494115·Integr Environ Assess Manag·2008
8-other
Actinic keratosis: an occupational and environmental disorder.
PMID 18410618·J Eur Acad Dermatol Venereol·2008
6-review
Evaluation of sources of uncertainty in risk assessments conducted for the US Army using a case study approach.
PMID 18260207·Integr Environ Assess Manag·2008
7-preclinical
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
PMID 18842902·J Neurosci·2008
7-preclinical
Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.
PMID 18178088·Bioorg Med Chem Lett·2008
8-other
Separating the wheat from the chaff: the effective use of mathematical models as decision tools.
PMID 17695115·Integr Environ Assess Manag·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 105 SPANISH CRT
ALBANY, GA 31707 - Phone
- (229) 438-7100
Quick Facts
- NPI
- 1386749117
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile